Author:
Belderbos Bodine P. S. I.,de Wit Ronald,Chien Caly,Mitselos Anna,Hellemans Peter,Jiao James,Yu Margaret K.,Attard Gerhardt,Bulat Iurie,Edenfield W. Jeffrey,Saad Fred
Funder
Janssen Research and Development
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference21 articles.
1. Ferlay JSI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2012) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11.
http://globocan.iarc.fr
. Accessed 28 Feb 2018
2. Gartrell BA, Saad F (2014) Managing bone metastases and reducing skeletal related events in prostate cancer. Nat Rev Clin Oncol 11(6):335–345.
https://doi.org/10.1038/nrclinonc.2014.70
3. Tan MH, Li J, Xu HE, Melcher K, Yong EL (2015) Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin 36(1):3–23.
https://doi.org/10.1038/aps.2014.18
4. ERLEADA [prescribing information] (2018). Available via Janssen website.
http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/ERLEADA-pi.pdf
. Accessed 2 July 2018
5. Clegg NJ, Wongvipat J, Joseph JD, Tran C, Ouk S, Dilhas A, Chen Y, Grillot K, Bischoff ED, Cai L, Aparicio A, Dorow S, Arora V, Shao G, Qian J, Zhao H, Yang G, Cao C, Sensintaffar J, Wasielewska T, Herbert MR, Bonnefous C, Darimont B, Scher HI, Smith-Jones P, Klang M, Smith ND, De Stanchina E, Wu N, Ouerfelli O, Rix PJ, Heyman RA, Jung ME, Sawyers CL, Hager JH (2012) ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Res 72(6):1494–1503.
https://doi.org/10.1158/0008-5472.CAN-11-3948
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献